Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the efficacy of Atorvastin vs Simvastatin in decreasing LDL-C in diabetic subjects with hypercholesterolemia at the end of the treatment phase.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Atorvastatin | Drug | |||
| Simvastatin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the decrease of LDL-C after 24 weeks of treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the changes from baseline of targeted blood markers. | ||
| To evaluate safety of Atorvastatin vs Simvastatin |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | S. Benedetto DEL Tronto | Ascoli Piceno | 63039 | Italy | ||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| S.Pietro Vernotico |
| Brindisi |
| Italy |
| Pfizer Investigational Site | Casarano | Lecce | 73043 | Italy |
| Pfizer Investigational Site | Pavia | PV | 27100 | Italy |
| Pfizer Investigational Site | Orbassano | Torino | 10043 | Italy |
| Pfizer Investigational Site | Mestre | VE | 30174 | Italy |
| Pfizer Investigational Site | Ancona | 60100 | Italy |
| Pfizer Investigational Site | Asti | 14100 | Italy |
| Pfizer Investigational Site | Bari | 70124 | Italy |
| Pfizer Investigational Site | Cagliari | 09134 | Italy |
| Pfizer Investigational Site | Campobasso | 86100 | Italy |
| Pfizer Investigational Site | Catania | 95124 | Italy |
| Pfizer Investigational Site | Catania | 95126 | Italy |
| Pfizer Investigational Site | Catanzaro | 88100 | Italy |
| Pfizer Investigational Site | Ferrara | 44100 | Italy |
| Pfizer Investigational Site | Genova | 16132 | Italy |
| Pfizer Investigational Site | Messina | 98158 | Italy |
| Pfizer Investigational Site | Milan | 20142 | Italy |
| Pfizer Investigational Site | Milan | 20145 | Italy |
| Pfizer Investigational Site | Milan | 20157 | Italy |
| Pfizer Investigational Site | Naples | 80100 | Italy |
| Pfizer Investigational Site | Naples | 80131 | Italy |
| Pfizer Investigational Site | Palermo | 90127 | Italy |
| Pfizer Investigational Site | Parma | 43100 | Italy |
| Pfizer Investigational Site | Perugia | 06100 | Italy |
| Pfizer Investigational Site | Pisa | 56124 | Italy |
| Pfizer Investigational Site | Potenza | 85100 | Italy |
| Pfizer Investigational Site | Rimini | 47900 | Italy |
| Pfizer Investigational Site | Roma | 00155 | Italy |
| Pfizer Investigational Site | Roma | 00161 | Italy |
| Pfizer Investigational Site | Roma | 00163 | Italy |
| Pfizer Investigational Site | Roma | 00168 | Italy |
| Pfizer Investigational Site | S. Benedetto Del Tronto (AP) | 63039 | Italy |
| Pfizer Investigational Site | Torino | 10154 | Italy |
| Pfizer Investigational Site | Udine | 33100 | Italy |
| ID | Term |
|---|---|
| D006937 | Hypercholesterolemia |
| ID | Term |
|---|---|
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069059 | Atorvastatin |
| D019821 | Simvastatin |
| ID | Term |
|---|---|
| D011758 | Pyrroles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D006538 | Heptanoic Acids |
| D005227 | Fatty Acids |
| D008055 | Lipids |
| D008148 | Lovastatin |
| D009281 | Naphthalenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D011083 | Polycyclic Compounds |
Not provided
Not provided